Research P Pharmaceutical Executive
Effective Methods of Accurately Measuring Tumors
Ignite Proteomics measures phosphorylation states to show which proteins are actively driving a tumor—guiding therapy beyond what IHC alone reveals.
Research headlines from across biotech and life sciences, gathered from the industry press and linked straight to the publisher. Every story links straight to its publisher.
Research P Pharmaceutical Executive
Ignite Proteomics measures phosphorylation states to show which proteins are actively driving a tumor—guiding therapy beyond what IHC alone reveals.
Research
Bio.News
The price Americans pay for the Inflation Reduction Act (IRA) “pill penalty” and disincentives for follow-on research is a reduction in new cancer treatments, […] The post Cancer drug study puts numbers to the cost of IRA’s pill penalty appeared first on Bio.News.
Research
Nature Reviews Drug Discovery
Research
Inside Precision Medicine
A new study suggests that VEGF-C expression in cells surrounding breast tumors, rather than the cancer cells themselves, may help predict lymph node metastasis and support more personalized surgical treatment. The post New Breast Cancer Biomarker Could Help Guide Less Invasive Su…
Research B BioPharm International
A real-world study found evolocumab cut fatal or nonfatal heart attack risk 20% vs ezetimibe in adults with ASCVD and prior statin use.
Research P Pharmaceutical Executive
The termination ends a cardiometabolic RNA-editing partnership that was paused for 12 months, closing out a deal under which Korro earned no milestone payments.
Research A Applied Clinical Trials
Risk-based quality management depends on knowing what to monitor and on interpreting what the signals mean.
Research
Clinical Trials Arena
Amgen has reported that its human monoclonal antibody Repatha lowered fatal or non-fatal heart attack risk by 20% in a real-world trial over ezetimibe in patients with ASCVD. The post Amgen’s Repatha reduces heart attack risk in real-world study appeared first on Clinical Trials…
Research B BioTechniques
Original story from McGill University (Montreal, Canada). Scientists have discovered a surprising ability in immune cells that could reshape our understanding of how the body develops lasting protection against infections. A McGill University-led (Montreal, Canada) study has unco…
Research
Inside Precision Medicine
A high-throughput drug screening platform uses DNA nanoswitches to identify compounds capable of changing how proteins interact. The post DNA Nanotechnology Speeds Up Discovery of New Drug Candidates appeared first on Inside Precision Medicine.
Research V Virological
Genomic characterization of the 2026 Bundibugyo virus disease outbreak in the Democratic Republic of the Congo Prepared by Tony Wawina-Bokalanga, Placide Mbala-Kingebeni, Tania Bishola Tshitenge, Dav M Ebengo, and Eddy Lusamaki (INRB) | Jonathan Pekar and Andrew Rambaut (Universi…
Research
GEN
The boundaries of what’s considered “druggable” are shifting as advances in cell and gene therapies expand the possibilities for cancer treatment. Expanded insights can open new avenues for biomarker research and therapeutic discovery. The post As Therapeutic Modalities Expand, G…
Research B BioPharm International
Boehringer Ingelheim will pay Sino Biopharmaceutical $358 million upfront and near-term for options on six biologic oncology programs, deepening a partnership that began in 2024.
Research
GEN
In this GEN eBook readers will discover how epigenomic insights are improving every stage of the drug discovery pipeline, from target identification and validation to mechanism-of-action studies and therapeutic optimization. The post How Epigenomics Is Transforming Drug Discovery…
Research A Applied Clinical Trials
Recruiting specialty volunteer populations can be one of the biggest challenges in early-phase clinical development, impacting timelines, costs, and data quality. This article outlines five key questions to ask when evaluating a CRO partner, helping sponsors identify recruitment…
Research N Nature Medicine
Research
GEN
Nightingale Health will run the measurements in its labs using Alamar’s NULISA platform to quantify hundreds of blood proteins in 80,000 UK Biobank samples, seeking early molecular signs of neurodegeneration. The post Alamar, Nightingale Health Team up on UK Biobank Neurodegenera…
Research A Applied Clinical Trials
Community participation gaps look less like a question of patient willingness and more like a financing and infrastructure problem that no single bill has yet solved.
Research P pharmaphorum
Case study backs YolTech's AATD gene therapy Phil.Taylor Tue, 03/11/2026 - 13:09
Research
Inside Precision Medicine
New long-term evidence suggests contemporary hormone replacement therapy does not increase the risk of heart disease, stroke, blood clots, or premature death in women who begin treatment before age 60. The post Modern Hormone Therapy Shows No Increased Heart Risk in Long-Term Stu…
Research P Pharmafile
Diagnostic innovation and patient safety have dominated this year’s healthcare-focussed awards to mark European Laboratory Day. Staged by the European Federation of Clinical Chemistry and Laboratory Medicine on 5 November the event also honours four young scientists selected…
Research S Science News
Scientists say work could help identify “castration mimetics” that boost longevity
Research N Nature Medicine
Research P Pharmaceutical Executive
Two teams can size the same market using the exact same healthcare claims data and land millions of patients apart. The data is identical, but the cohort definition is not, and almost nobody checks the range. While real-world data can map treatment flows, disease progression, out…
Research P Pharmaceutical Executive
Two teams can size the same market using the exact same healthcare claims data and land millions of patients apart. The data is identical, but the cohort definition is not, and almost nobody checks the range. While real-world data can map treatment flows, disease progression, out…
Research
Clinical Trials Arena
Starton Therapeutics has entered a clinical trial agreement with the Stanford School of Medicine to assess its STAR-LLD candidate alongside a new CAR-T cell therapy for MM. The post Starton and Stanford to study STAR-LLD combination in MM appeared first on Clinical Trials Arena.
Research S Science News
NIH’s arguments opposing the union don’t hold up, ruled a federal entity that oversees labor relations
Research
Inside Precision Medicine
Two major studies have identified the most accurate non-invasive tests for diagnosing and assessing the severity of metabolic dysfunction-associated steatotic liver disease (MASLD), potentially reducing the need for liver biopsies. The post Most Accurate Non-Invasive Tests for Li…
Research
Inside Precision Medicine
A new single-cell proteomics approach has revealed distinct immune-cell protein signatures associated with oral cancer progression and lymph node involvement. The findings could pave the way for noninvasive saliva tests to help assess disease progression and identify patients at…
Research B BioPharm International
Updated phase 2 IOV-LUN-202 data show Iovance’s TIL cell therapy lifileucel produced a 24.6% response rate in previously treated non-squamous metastatic NSCLC, rising to 52.0% in KRAS and HER2 wild-type patients, as the company launches a biomarker-enriched registrational cohort.
Research P PLOS Biology
by Eva Bons, Hélène Chabas, Hannelore MacDonald, Alejandro Escalera Ledermann, Sira Ösze, Jenny Dunstan, Nicolas Ochsner, Daniel C. Angst, Sebastian Bonhoeffer, Roland R. Regoes The study of evolution in organisms with high mutation rates requires detailed data on the genomic com…
Research A Applied Clinical Trials
In this video interview, Kent Thoelke, CEO of Paradigm Health, explains why patients in community and rural settings too often lack access to clinical research as a care option, and how closing that gap could improve outcomes and lower long-term costs.
Research B BioTechniques
Take a peek behind the paper: A refined qPCR duplexing method for the molecular sex determination of sturgeon (Acipenser genus), providing a validating, endogenous control. Recently published in BioTechniques, this work introduces an optimized qPCR duplexing method for sex i…
Research B BioPharm International
Webinar Date/Time: Wed, Nov 18, 2026 11:00 AM EST
Research
GEN
A controlled human trial reveals how preexisting antibodies influence dengue virus replication and immune responses, offering insights to develop safer, more broadly protective vaccines against all four dengue strains. The post Human Dengue Study Reveals How Preexisting Immunity…
Research B BioPharm International
Direct-to-Biology workflows move crude reaction mixtures straight into assays, giving hit-to-lead teams earlier data to guide series selection.
Research P PLOS Biology
by Thomas S. Lewis, Jessica Wagner, Jonas J. Neher Molecular profiling studies have mapped vascular alterations in Alzheimer’s disease, but have not proven a role for them in pathology. Longitudinal studies are needed to link molecular and structural changes to vascular mechanics…
Research
STAT Biotech
Eli Lilly announced that its investigational drug retatrutide was more effective at lowering blood sugar and cutting weight than Novo Nordisk’s Ozempic in a large diabetes study.
Research
STAT Biotech
Data add to expectations that the drug will be one of Lilly’s greatest growth drivers.
Research
GEN
GEN editors Uduak Thomas and Julianna LeMieux, PhD, recap ASHG, highlighting key sessions, Ultima Genomics’ user group meeting, Illumina news, and insights from PacBio’s new CEO Mark Van Oene. The post Bonjour Genomics: A Video from ASHG appeared first on GEN - Genetic Engineerin…